A Study to Evaluate AP-101 in Familial and Sporadic Amyotrophic Lateral Sclerosis (ALS)

Condition:   Amyotrophic Lateral Sclerosis Intervention:   Drug: AP-101 Sponsor:   AL-S Pharma Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials